Zhi-Cheng Jin

ORCID

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 12

Top Venues

United European gastroenterology journal

Signal transduction and targeted therapy

Journal of clinical and translational hepatology

Hepatology (Baltimore, Md.)

This page only lists publications with an associated author ORCID identifier.

Publications

Jian-Jian Chen, Zhi-Cheng Jin, Bin-Yan Zhong, Wenzhe Fan, Wei-Hua Zhang, Biao Luo, Yu-Qing Wang, Gao-Jun Teng, Hai-Dong Zhu
Locoregional therapies for hepatocellular carcinoma: The current status and future perspectives. United European gastroenterology journal (2024)
Jian-Jian Chen, Zhi-Cheng Jin, Bin-Yan Zhong, Wenzhe Fan, Wei-Hua Zhang, Biao Luo, Yu-Qing Wang, Gao-Jun Teng, Hai-Dong Zhu
Locoregional therapies for hepatocellular carcinoma: The current status and future perspectives. United European gastroenterology journal 12 (2) (2024)
Jian-Jian Chen, Zhi-Cheng Jin, Bin-Yan Zhong, Wenzhe Fan, Wei-Hua Zhang, Biao Luo, Yu-Qing Wang, Gao-Jun Teng, Hai-Dong Zhu
Locoregional therapies for hepatocellular carcinoma: The current status and future perspectives. United European gastroenterology journal 12 (2) (2024)
Jian-Jian Chen, Zhi-Cheng Jin, Bin-Yan Zhong, Wenzhe Fan, Wei-Hua Zhang, Biao Luo, Yu-Qing Wang, Gao-Jun Teng, Hai-Dong Zhu
Locoregional therapies for hepatocellular carcinoma: The current status and future perspectives. United European gastroenterology journal 12 (2) (2024)
Jian-Jian Chen, Zhi-Cheng Jin, Bin-Yan Zhong, Wenzhe Fan, Wei-Hua Zhang, Biao Luo, Yu-Qing Wang, Gao-Jun Teng, Hai-Dong Zhu
Locoregional therapies for hepatocellular carcinoma: The current status and future perspectives. United European gastroenterology journal 12 (2) (2024)
Hai-Dong Zhu, Hai-Liang Li, Ming-Sheng Huang, Wei-Zhu Yang, Guo-Wen Yin, Bin-Yan Zhong, Jun-Hui Sun, Zhi-Cheng Jin, Jian-Jian Chen, Nai-Jian Ge, Wen-Bin Ding, Wen-Hui Li, Jin-Hua Huang, Wei Mu, Shan-Zhi Gu, Jia-Ping Li, Hui Zhao, Shu-Wei Wen, Yan-Ming Lei, Yu-Sheng Song, Chun-Wang Yuan, Wei-Dong Wang, Ming Huang, Wei Zhao, Jian-Bing Wu, Song Wang, Xu Zhu, Jian-Jun Han, Wei-Xin Ren, Zai-Ming Lu, Wen-Ge Xing, Yong Fan, Hai-Lan Lin, Zi-Shu Zhang, Guo-Hui Xu, Wen-Hao Hu, Qiang Tu, Hong-Ying Su, Chuan-Sheng Zheng, Yong Chen, Xu-Ya Zhao, Zhu-Ting Fang, Qi Wang, Jin-Wei Zhao, Ai-Bing Xu, Jian Xu, Qing-Hua Wu, Huan-Zhang Niu, Jian Wang, Feng Dai, Dui-Ping Feng, Qing-Dong Li, Rong-Shu Shi, Jia-Rui Li, Guang Yang, Hai-Bin Shi, Jian-Song Ji, Yu-E Liu, Zheng Cai, Po Yang, Yang Zhao, Xiao-Li Zhu, Li-Gong Lu, Gao-Jun Teng, null null
Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001). Signal transduction and targeted therapy 8 (1) (2023)
Jian-Jian Chen, Zhi-Cheng Jin, Biao Luo, Yu-Qing Wang, Rui Li, Hai-Dong Zhu, Gao-Jun Teng
New First-line Immunotherapy-based Therapies for Unresectable Hepatocellular Carcinoma: A Living Network Meta-analysis. Journal of clinical and translational hepatology 12 (1) (2023)
Jian-Jian Chen, Zhi-Cheng Jin, Biao Luo, Yu-Qing Wang, Rui Li, Hai-Dong Zhu, Gao-Jun Teng
New First-line Immunotherapy-based Therapies for Unresectable Hepatocellular Carcinoma: A Living Network Meta-analysis. Journal of clinical and translational hepatology 12 (1) (2023)
Hai-Dong Zhu, Hai-Liang Li, Ming-Sheng Huang, Wei-Zhu Yang, Guo-Wen Yin, Bin-Yan Zhong, Jun-Hui Sun, Zhi-Cheng Jin, Jian-Jian Chen, Nai-Jian Ge, Wen-Bin Ding, Wen-Hui Li, Jin-Hua Huang, Wei Mu, Shan-Zhi Gu, Jia-Ping Li, Hui Zhao, Shu-Wei Wen, Yan-Ming Lei, Yu-Sheng Song, Chun-Wang Yuan, Wei-Dong Wang, Ming Huang, Wei Zhao, Jian-Bing Wu, Song Wang, Xu Zhu, Jian-Jun Han, Wei-Xin Ren, Zai-Ming Lu, Wen-Ge Xing, Yong Fan, Hai-Lan Lin, Zi-Shu Zhang, Guo-Hui Xu, Wen-Hao Hu, Qiang Tu, Hong-Ying Su, Chuan-Sheng Zheng, Yong Chen, Xu-Ya Zhao, Zhu-Ting Fang, Qi Wang, Jin-Wei Zhao, Ai-Bing Xu, Jian Xu, Qing-Hua Wu, Huan-Zhang Niu, Jian Wang, Feng Dai, Dui-Ping Feng, Qing-Dong Li, Rong-Shu Shi, Jia-Rui Li, Guang Yang, Hai-Bin Shi, Jian-Song Ji, Yu-E Liu, Zheng Cai, Po Yang, Yang Zhao, Xiao-Li Zhu, Li-Gong Lu, Gao-Jun Teng, null null
Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001). Signal transduction and targeted therapy 8 (1) (2023)
Hai-Dong Zhu, Hai-Liang Li, Ming-Sheng Huang, Wei-Zhu Yang, Guo-Wen Yin, Bin-Yan Zhong, Jun-Hui Sun, Zhi-Cheng Jin, Jian-Jian Chen, Nai-Jian Ge, Wen-Bin Ding, Wen-Hui Li, Jin-Hua Huang, Wei Mu, Shan-Zhi Gu, Jia-Ping Li, Hui Zhao, Shu-Wei Wen, Yan-Ming Lei, Yu-Sheng Song, Chun-Wang Yuan, Wei-Dong Wang, Ming Huang, Wei Zhao, Jian-Bing Wu, Song Wang, Xu Zhu, Jian-Jun Han, Wei-Xin Ren, Zai-Ming Lu, Wen-Ge Xing, Yong Fan, Hai-Lan Lin, Zi-Shu Zhang, Guo-Hui Xu, Wen-Hao Hu, Qiang Tu, Hong-Ying Su, Chuan-Sheng Zheng, Yong Chen, Xu-Ya Zhao, Zhu-Ting Fang, Qi Wang, Jin-Wei Zhao, Ai-Bing Xu, Jian Xu, Qing-Hua Wu, Huan-Zhang Niu, Jian Wang, Feng Dai, Dui-Ping Feng, Qing-Dong Li, Rong-Shu Shi, Jia-Rui Li, Guang Yang, Hai-Bin Shi, Jian-Song Ji, Yu-E Liu, Zheng Cai, Po Yang, Yang Zhao, Xiao-Li Zhu, Li-Gong Lu, Gao-Jun Teng, null null
Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001). Signal transduction and targeted therapy 8 (1) (2023)
Hai-Dong Zhu, Hai-Liang Li, Ming-Sheng Huang, Wei-Zhu Yang, Guo-Wen Yin, Bin-Yan Zhong, Jun-Hui Sun, Zhi-Cheng Jin, Jian-Jian Chen, Nai-Jian Ge, Wen-Bin Ding, Wen-Hui Li, Jin-Hua Huang, Wei Mu, Shan-Zhi Gu, Jia-Ping Li, Hui Zhao, Shu-Wei Wen, Yan-Ming Lei, Yu-Sheng Song, Chun-Wang Yuan, Wei-Dong Wang, Ming Huang, Wei Zhao, Jian-Bing Wu, Song Wang, Xu Zhu, Jian-Jun Han, Wei-Xin Ren, Zai-Ming Lu, Wen-Ge Xing, Yong Fan, Hai-Lan Lin, Zi-Shu Zhang, Guo-Hui Xu, Wen-Hao Hu, Qiang Tu, Hong-Ying Su, Chuan-Sheng Zheng, Yong Chen, Xu-Ya Zhao, Zhu-Ting Fang, Qi Wang, Jin-Wei Zhao, Ai-Bing Xu, Jian Xu, Qing-Hua Wu, Huan-Zhang Niu, Jian Wang, Feng Dai, Dui-Ping Feng, Qing-Dong Li, Rong-Shu Shi, Jia-Rui Li, Guang Yang, Hai-Bin Shi, Jian-Song Ji, Yu-E Liu, Zheng Cai, Po Yang, Yang Zhao, Xiao-Li Zhu, Li-Gong Lu, Gao-Jun Teng, null null
Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001). Signal transduction and targeted therapy 8 (1) (2023)
Zhi-Cheng Jin, Jian-Jian Chen, Biao Luo, Wei-Hua Zhang, Gao-Jun Teng
Letter to the editor: Hepatitis B virus reactivation in immune checkpoint inhibitor-based combination therapies for hepatocellular carcinoma. Hepatology (Baltimore, Md.) (2022)

Zhi-Cheng Jin.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Zhi-Cheng Jin